- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05312775
Niche In CEsarean Scar Trial (NICEST)
Single Versus Double-layer Closure of The Cesarean Scar In Niche Development: A Randomized Clinical Trial
Rationale: Cesarean delivery (CD) rates are increasing rapidly worldwide. The consequences of cesarean section not only affect the next pregnancies such as uterine rupture or malplacentation but also cause many gynecological complications or infertility due to the formation of cesarean scar defect (CSD) or Niche. One of the major factors for Niche formation is the techniques of hysterotomy closure at the time of cesarean delivery. Most common hysterotomy closures include single and double layers closure. However, there is limited literature to prove which technique decreases niche creation and associated gynecological complications.
Objective: To compare the effect of uterine closure techniques during CD on the formation of Niche evaluated on transvaginal ultrasound and gynecological complications.
Study design: a double-blinded, single-center, randomized clinical trial. Setting: Hanoi Obstetrics & Gynecology Hospital (HOGH), Viet Nam. Study population: All women at gestational age ≥ 37 0/7 weeks who undergo a primary CD (planned or unplanned).
Intervention: After informed consent, women will be randomized to either unlocked single layer closure or unlocked double-layer closures of cesarean uterine scar in a 1:1 ratio Primary outcome: The proportion of Niche over time (at 6, 12, 18, 24 months after CD) in the two groups.
Power calculation: A sample size of 389 women is needed for each group. Nature and extent of the burden and risks associated with participation, benefit, and group relatedness: Both uterine closure methods followed by the Vietnam Ministry of Health (VN-MOH), transvaginal ultrasound is also not harmful. It is believed that there are no potential increased risks to patients taking part in this trial because of the standard care and management they receive.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pregnancies at term, indicated for cesarean delivery for the first time, will be fully consulted information related to this study before surgery. Written consent will be obtained from each eligible pregnant woman before randomization into the study.
After signing the informed consent form, eligible women will be randomly assigned in a 1:1 ratio to receive either single-layer closure or double-layer closure, using block randomization with a variable block size of 4, 6. The computer-generated random list will be prepared by an independent statistician who has no other involvement in the study. To ensure allocation concealment, opaque and sealed envelopes will be prepared and controlled by two administrative staff in the Clinical Trial Unit who have no involvement in clinical work. Whenever there is an eligible participant, these two staff will hand over the envelope in sequence to the clinician. As the result, surgeons will not be blinded, but participants and sonographers will be unaware of closure techniques. Apart from randomization, patients will be followed up and treated according to local protocol.
The cesarean section with two uterine scar closure techniques will be performed by well-trained obstetricians. Participants and sonographers will be blinded for the closure technique.
Intervention (double-layer closure) In both study groups, women will undergo a CD following a standard way with respect to the mode of hysterotomy, non-closure of the peritoneum. In the intervention group, double-layer closure of the uterus will be performed using unlocked multifilament continuous running sutures for both layers and the endometrial layer will be included in the first layer. The second layer is a continuous running suture that imbricates the first layer.
Control group (single-layer closure) The control group will receive a single-layer closure using unlocked continuous running multifilament sutures and the endometrial layer will be included.
Complication during surgery
The cases that have complications during surgery will be excluded from the study. Complications encompass:
- Maternal mortality
- Maternal admitted ICU
- Hysterectomy
- Damage to internal organs (bowel, bladder or ureters).
- Complications during postoperative period requiring further surgery. Follow-up Participants will be contacted via telephone to notify about follow-up visits within 10 days of the first day of every menstrual cycle at 6 months, 12 months, 18 months, 24 months (give or take 2 weeks).
Every regular follow-up visit, the participants will be examined and transvaginal ultrasound followed by saline infusion sonohysterography to evaluate Niche. The ultrasound evaluation is standardized as proposed by the latest standard of ISUOG(2019).
Reproductive outcomes at two years follow-up: Percentage of women that conceived at any time during the follow-up duration, time of conception, and results of said pregnancies (ongoing pregnancy, terminated pregnancy due to medical/ social indication).
Niche evaluation Every regular follow-up visit, the participants will be examined and transvaginal ultrasound followed by sonohysterography to evaluate Niche. The Niche evaluation is standardized as proposed by the latest standard of ISUOG(2019).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ha TT Nguyen, PhD.MD
- Phone Number: 0989661093
- Email: dr.hanguyen@hogh.vn
Study Contact Backup
- Name: Giang TT Duong, MD
- Phone Number: 0084972186390
- Email: dttgnts41@gmail.com
Study Locations
-
-
Hanoi
-
Hà Nội, Hanoi, Vietnam, 100000
- Recruiting
- Hanoi Obstetrics and Gynecology Hospital
-
Contact:
- Giang TT Duong, MD
- Phone Number: 0084972186390
- Email: dttgnts41@gmail.com
-
Contact:
- Ha TT Nguyen Thi Thu, MD.PhD
- Phone Number: 0084989661093
- Email: thuha.ivf@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant women who undergo a primary CD (planned or unplanned)
- Age ≥ 18 years.
- Gestational age ≥ 37 0/7 weeks
Exclusion Criteria:
- Previous major uterine surgery (e.g. laparoscopic or laparotomic fibroid resection, septum resection).
- Women with abnormal menstrual bleeding (e.g. cervical dysplasia, communicating hydrosalpinx, uterine anomaly or endocrine disorders disturbing ovulation, drugs, polyps, fibroids, etc.).
- Women with dysmenorrhea, dyspareunia, suprapubic pain.
- Abnormal placenta: Placenta privia, Placenta percreta… in the current pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Single-layer uterine closure
Women will undergo a CD following a standard way with respect to the mode of hysterotomy, non-closure of the peritoneum.
The control group will receive a single-layer closure using unlocked continuous running multifilament sutures and the endometrial layer will be included
|
The control group will receive a single-layer closure using unlocked continuous running multifilament sutures and the endometrial layer will be included
|
|
Active Comparator: Double-layer uterine closure
Women will undergo a CD following a standard way with respect to the mode of hysterotomy, non-closure of the peritoneum.
In the intervention group, double-layer closure of the uterus will be performed using unlocked multifilament continuous running sutures for both layers and the endometrial layer will be included in the first layer.
The second layer is a continuous running suture that imbricates the first layer
|
In the intervention group, double-layer closure of the uterus will be performed using unlocked multifilament continuous running sutures for both layers and the endometrial layer will be included in the first layer.
The second layer is a continuous running suture that imbricates the first layer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The proportion of Niche at 6 months after cesarean delivery of Single-layer uterine closure group
Time Frame: from delivery to 6 months from delivery
|
The proportion of Niche at 6 months after cesarean delivery of Single-layer uterine closure group.
|
from delivery to 6 months from delivery
|
|
The proportion of Niche at 12 months after cesarean delivery of Single-layer uterine closure group
Time Frame: from delivery to 12 months from delivery
|
The proportion of Niche at 12 months after cesarean delivery of Single-layer uterine closure group.
|
from delivery to 12 months from delivery
|
|
The proportion of Niche at 18 months after cesarean delivery of Single-layer uterine closure group
Time Frame: from delivery to 18 months from delivery
|
The proportion of Niche at 18 months after cesarean delivery of Single-layer uterine closure group.
|
from delivery to 18 months from delivery
|
|
The proportion of Niche at 24 months after cesarean delivery of Single-layer uterine closure group
Time Frame: from delivery to 24 months from delivery
|
The proportion of Niche at 24 months after cesarean delivery of Single-layer uterine closure group.
|
from delivery to 24 months from delivery
|
|
The proportion of Niche at 6 months after cesarean delivery of Double-layer uterine closure group
Time Frame: from delivery to 6 months from delivery)
|
The proportion of Niche at 6 months after cesarean delivery of Double-layer uterine closure group.
|
from delivery to 6 months from delivery)
|
|
The proportion of Niche at 12 months after cesarean delivery of Double-layer uterine closure group
Time Frame: from delivery to 12 months from delivery
|
The proportion of Niche at 12 months after cesarean delivery of Double-layer uterine closure group.
|
from delivery to 12 months from delivery
|
|
The proportion of Niche at 18 months after cesarean delivery of Double-layer uterine closure group
Time Frame: from delivery to 18 months from delivery
|
The proportion of Niche at 18 months after cesarean delivery of Double-layer uterine closure group.
|
from delivery to 18 months from delivery
|
|
The proportion of Niche at 24 months after cesarean delivery of Double-layer uterine closure group
Time Frame: from delivery to 24 months from delivery
|
The proportion of Niche at 24 months after cesarean delivery of Double-layer uterine closure group.
|
from delivery to 24 months from delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with post-partum hemorrhage.
Time Frame: Within 24 hours from delivery
|
Defined as blood loss more than 1000ml with 24 hours after cesarean delivery
|
Within 24 hours from delivery
|
|
Number of participants having uterine atony
Time Frame: During operation
|
Defined as use of two or more uterotonics other oxytocin; other surgical interventions such as compression by hand and/or sutures, uterine arteries ligation, embolization, hypogastric arteries ligation, or balloon tamponade
|
During operation
|
|
Number of participants with maternal infection
Time Frame: from delivery until maternal hospital discharge, assessed up to 28 days after delivery
|
Maternal infection as defined:
|
from delivery until maternal hospital discharge, assessed up to 28 days after delivery
|
|
Number of participants having postmenstrual spotting in women with Niche
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Postmenstrual spotting is brownish discharge for more than two days at the end of menstruation with a total duration (menstruation and spotting) of more than seven days, or intermenstrual bleeding that starts after the end of menstruation, assessed at 6 months, 12 months, 18 months and 24 months after delivery.
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Duration of postmenstrual spotting in women with Niche
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Duration of postmenstrual spotting in women with Niche defined as the average number of days of postmenstrual spotting in 6 months, in which duration of postmenstrual spotting in each month will be counted as follows: days with brownish discharge (more than two days) when the total duration of menstruation and spotting exceeds seven days plus days with intermenstrual bleeding, assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery.
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Number of participants suffering from dysmenorrhea in women with Niche
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Number of participants suffering from dysmenorrhea in women with Niche, assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Dysmenorrhea severity in women with Niche
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Participants with dysmenorrhea self-assessed pain levels and scored 1 to 10 rely on the Numeric Rating Scale (NRS).
The average score in span of 6 months will be calculated and the highest score will be noticed to reveal dysmenorrhea severity at 6 months, 12 months, 18 months, 24 months after cesarean delivery
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Number of participants suffering from suprapubic pain in women with Niche
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Number of participants suffering from suprapubic pain in women with Niche, assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Suprapubic pain severity in women with Niche
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Participants with suprapubic pain self-assessed pain levels and scored 1 to 10 rely on the Numeric Rating Scale (NRS).
The average score in span of 6 months will be calculated and the highest score will be noticed to reveal suprapubic pain severity at 6 months, 12 months, 18 months, 24 months after cesarean delivery
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Number of participants suffering from dyspareunia in women with Niche
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Number of participants suffering from dyspareunia in women with Niche, assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Dyspareunia severity in women with Niche
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Participants with dyspareunia self-assessed pain levels and scored 1 to 10 rely on the Numeric Rating Scale (NRS).
The average score in span of 6 months will be calculated and the highest score will be noticed to reveal dyspareunia severity at 6 months, 12 months, 18 months, 24 months after delivery
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Niche length
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
The length at Niche base will be measured in the sagittal plane on transvaginal ultrasound, assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery.
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Niche depth
Time Frame: : from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
The largest depth of Niche will be measured in the sagittal plane on ultrasound, assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery.
|
: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Number of branches of Niche
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Number of branches of Niche will be measured in the transverse plane on transvaginal ultrasound, assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery.
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Residual myometrial thickness (RMT)
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Thinnest point of residual myometrial thickness will be measured in the sagittal plane on transvaginal ultrasound, regardless of direction (measured perpendicular to serosa but not necessarily to uterine cavity), from the main Niche or branch with the thinnest RMT.
Fibroid is not included in RMT measurement, assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery.
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Ratio of residual myometrial thickness per adjacent myometrial thickness (RMT/AMT)
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Adjacent myometrial thickness will be measured close to Niche in the sagittal plane on transvaginal ultrasound, where myometrium is thickness.
Ratio of RMT/AMT will be assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery.
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Niche-vesicovaginal fold distance
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Distance between Niche and vesicovaginal fold will be measured in the sagittal plane on transvaginal ultrasound, from level of top main Niche (where residual myometrial thickness is smallest (dotted line)) to vesicovaginal fold, assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery.
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Niche-external os distance
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Distance between niche and external os will be measured parallel to cervical canal, from most distal point of niche to external os in the sagittal plane on transvaginal ultrasound, assessed at 6 months, 12 months, 18 months and 24 months after cesarean delivery.
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Evaluating the correlation between Niche characteristics and gynecological symptoms
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Correlation between characteristics of Niche (include length, depth, branches, RMT, RMT/AMT, Niche-vesicovaginal fold distance and Niche-external os distance) and gynecological symptoms (involve postmenstrual spotting, dysmenorrhea, suprapubic pain and dyspareunia) will be analyzed at 6 months, 12 months, 18 months and 24 months after cesarean delivery
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Evaluating factors contributing to Niche development
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Correlation between Niche formation and risk factors include labor (cervical dilation, duration of labor), planned or unplanned cesarean section, maternal factors, short-term outcomes such as uterine atony, post-partum hemorrhage, post-partum blood transfusion, maternal infection will be analyzed at 6 months, 12 months, 18 months and 24 months after cesarean delivery
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
|
Comparison between the rate of niche detection by regular TVUS and sonohysterography
Time Frame: from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Comparison between rate of niche detection (percentage) in all follow-up events by regular TVUS and sonohysterography
|
from delivery to 6 months, 12 months, 18 months, 24 months after cesarean delivery, up to 24 months from delivery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reproductive outcome during 2 years of follow-up
Time Frame: 24 months from delivery
|
Percentage of women that conceived at any time during 2 years of follow-up
|
24 months from delivery
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Anh D Nguyen, PhD. MD, Hanoi Obstetric and Gynecology Hospital
- Study Chair: Yves Ville, PhD. MD, Hôpital Necker-Enfants Malades
- Principal Investigator: Ha TT Nguyen, PhD.MD, Hanoi Obstetric and Gynecology Hospital
- Principal Investigator: Giang TT Duong, MD, Hanoi Obstetric and Gynecology Hospital
Publications and helpful links
General Publications
- Bij de Vaate AJ, van der Voet LF, Naji O, Witmer M, Veersema S, Brolmann HA, Bourne T, Huirne JA. Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following Cesarean section: systematic review. Ultrasound Obstet Gynecol. 2014 Apr;43(4):372-82. doi: 10.1002/uog.13199.
- Jordans IPM, de Leeuw RA, Stegwee SI, Amso NN, Barri-Soldevila PN, van den Bosch T, Bourne T, Brolmann HAM, Donnez O, Dueholm M, Hehenkamp WJK, Jastrow N, Jurkovic D, Mashiach R, Naji O, Streuli I, Timmerman D, van der Voet LF, Huirne JAF. Sonographic examination of uterine niche in non-pregnant women: a modified Delphi procedure. Ultrasound Obstet Gynecol. 2019 Jan;53(1):107-115. doi: 10.1002/uog.19049.
- Di Spiezio Sardo A, Saccone G, McCurdy R, Bujold E, Bifulco G, Berghella V. Risk of Cesarean scar defect following single- vs double-layer uterine closure: systematic review and meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol. 2017 Nov;50(5):578-583. doi: 10.1002/uog.17401. Epub 2017 Oct 9.
- Clark EA, Silver RM. Long-term maternal morbidity associated with repeat cesarean delivery. Am J Obstet Gynecol. 2011 Dec;205(6 Suppl):S2-10. doi: 10.1016/j.ajog.2011.09.028. Epub 2011 Oct 6.
- Naji O, Wynants L, Smith A, Abdallah Y, Saso S, Stalder C, Van Huffel S, Ghaem-Maghami S, Van Calster B, Timmerman D, Bourne T. Does the presence of a Caesarean section scar affect implantation site and early pregnancy outcome in women attending an early pregnancy assessment unit? Hum Reprod. 2013 Jun;28(6):1489-96. doi: 10.1093/humrep/det110. Epub 2013 Apr 12.
- Roberge S, Demers S, Berghella V, Chaillet N, Moore L, Bujold E. Impact of single- vs double-layer closure on adverse outcomes and uterine scar defect: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014 Nov;211(5):453-60. doi: 10.1016/j.ajog.2014.06.014. Epub 2014 Jun 6.
- Dodd JM, Anderson ER, Gates S, Grivell RM. Surgical techniques for uterine incision and uterine closure at the time of caesarean section. Cochrane Database Syst Rev. 2014 Jul 22;(7):CD004732. doi: 10.1002/14651858.CD004732.pub3.
- Delport S. Global epidemiology of use of and disparities in caesarean sections. Lancet. 2019 Jul 6;394(10192):23-24. doi: 10.1016/S0140-6736(19)30717-2. Epub 2019 Jul 4. No abstract available.
- Naji O, Wynants L, Smith A, Abdallah Y, Stalder C, Sayasneh A, McIndoe A, Ghaem-Maghami S, Van Huffel S, Van Calster B, Timmerman D, Bourne T. Predicting successful vaginal birth after Cesarean section using a model based on Cesarean scar features examined by transvaginal sonography. Ultrasound Obstet Gynecol. 2013 Jun;41(6):672-8. doi: 10.1002/uog.12423.
- Hesselman S, Hogberg U, Ekholm-Selling K, Rassjo EB, Jonsson M. The risk of uterine rupture is not increased with single- compared with double-layer closure: a Swedish cohort study. BJOG. 2015 Oct;122(11):1535-41. doi: 10.1111/1471-0528.13015. Epub 2014 Aug 4.
- Hanacek J, Vojtech J, Urbankova I, Krcmar M, Krepelka P, Feyereisl J, Krofta L. Ultrasound cesarean scar assessment one year postpartum in relation to one- or two-layer uterine suture closure. Acta Obstet Gynecol Scand. 2020 Jan;99(1):69-78. doi: 10.1111/aogs.13714. Epub 2019 Sep 26.
- Stegwee SI, Jordans IPM, van der Voet LF, Bongers MY, de Groot CJM, Lambalk CB, de Leeuw RA, Hehenkamp WJK, van de Ven PM, Bosmans JE, Pajkrt E, Bakkum EA, Radder CM, Hemelaar M, van Baal WM, Visser H, van Laar JOEH, van Vliet HAAM, Rijnders RJP, Sueters M, Janssen CAH, Hermes W, Feitsma AH, Kapiteijn K, Scheepers HCJ, Langenveld J, de Boer K, Coppus SFPJ, Schippers DH, Oei ALM, Kaplan M, Papatsonis DNM, de Vleeschouwer LHM, van Beek E, Bekker MN, Huisjes AJM, Meijer WJ, Deurloo KL, Boormans EMA, van Eijndhoven HWF, Huirne JAF. Single- versus double-layer closure of the caesarean (uterine) scar in the prevention of gynaecological symptoms in relation to niche development - the 2Close study: a multicentre randomised controlled trial. BMC Pregnancy Childbirth. 2019 Mar 4;19(1):85. doi: 10.1186/s12884-019-2221-y.
- Dahlke JD, Mendez-Figueroa H, Maggio L, Sperling JD, Chauhan SP, Rouse DJ. The Case for Standardizing Cesarean Delivery Technique: Seeing the Forest for the Trees. Obstet Gynecol. 2020 Nov;136(5):972-980. doi: 10.1097/AOG.0000000000004120.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PSHN.0005.2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Niche
-
International Peace Maternity and Child Health...Completed
-
Sohag UniversityNot yet recruitingCesarean Section Niche Evaluation
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Benha UniversityCompletedCesarean Section Complications | Scarred Uterus | Scar NicheEgypt
-
Kanuni Sultan Suleyman Training and Research HospitalRecruitingUterine Niche | Closure; Incomplete, UterusTurkey
-
Assiut UniversityUnknown
-
Amira Hasan AbdelhadyActive, not recruiting
-
Benha UniversityCompletedCesarean Section Complications | Contraceptive Device; Complications | Myometrial Remodeling | Scar NicheEgypt
-
Benha UniversityCompletedCesarean Section Complications | Myometrial Remodeling | Suture Techniques | Scar NicheEgypt
-
University of AarhusRanders Regional HospitalActive, not recruitingCesarean Scar NicheDenmark
Clinical Trials on Single-layer uterine closure
-
Hédi Chaker HospitalCompletedPelvic Pain | Metrorrhagia | Amenorrhea Secondary | Spotting | Cesarean Scar Defect (Isthmococele)Tunisia
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Tokat Gaziosmanpasa UniversityCompletedCesarean Section Complications | IsthmoceleTurkey
-
Tanta UniversityCompletedCaesarean Section | Transvaginal Ultrasound | Uterine Scar | Single Layer | Double LayerEgypt
-
Ataturk UniversityCompletedCesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
University Tunis El ManarCompleted
-
Abouqir General HospitalAlexandria UniversityCompletedSurgical Wound Closure TechniqueEgypt
-
Mount Sinai Hospital, CanadaCompletedCesarean Section Complications | Uterine Scar Diverticulum | Uterine Scar From Previous Cesarean DeliveryCanada
-
Korea University Guro HospitalJohnson and Johnson Medical Korea LtdNot yet recruitingScar Quality Assessment and Safety
-
Tanta UniversityRecruitingVentral Hernia | Incisional Hernia | Abdominal Wall WoundEgypt